| Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive care medicine 46, 1127-1153, 2020 | 589 | 2020 |
| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 518 | 2018 |
| Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ... European Respiratory Journal 56 (1), 2020 | 489 | 2020 |
| Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents RJM Brüggemann, JWC Alffenaar, NMA Blijlevens, EM Billaud, ... Clinical Infectious Diseases 48 (10), 1441-1458, 2009 | 480 | 2009 |
| Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement C Lange, I Abubakar, JWC Alffenaar, G Bothamley, JA Caminero, ... European Respiratory Journal 44 (1), 23-63, 2014 | 424 | 2014 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 367 | 2017 |
| Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot–based methods for … S Capiau, H Veenhof, RA Koster, Y Bergqvist, M Boettcher, O Halmingh, ... Therapeutic Drug Monitoring 41 (4), 409-430, 2019 | 235 | 2019 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 226 | 2020 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 221 | 2020 |
| Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis IS Pradipta, LD Forsman, J Bruchfeld, E Hak, JW Alffenaar Journal of Infection 77 (6), 469-478, 2018 | 211 | 2018 |
| Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB S De Lorenzo, JW Alffenaar, G Sotgiu, R Centis, L D'Ambrosio, S Tiberi, ... European Respiratory Journal 41 (6), 1386-1392, 2013 | 209 | 2013 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ... European Respiratory Journal 54 (6), 2019 | 187 | 2019 |
| Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume DH Vu, RA Koster, JWC Alffenaar, J Brouwers, DRA Uges Journal of Chromatography B 879 (15-16), 1063-1070, 2011 | 182 | 2011 |
| Bedaquiline resistance: its emergence, mechanism, and prevention TVA Nguyen, RM Anthony, AL Bañuls, TVA Nguyen, DH Vu, ... Clinical Infectious Diseases 66 (10), 1625-1630, 2018 | 162 | 2018 |
| Therapeutic drug monitoring of posaconazole: an update BGJ Dekkers, M Bakker, KCM van der Elst, MGG Sturkenboom, A Veringa, ... Current fungal infection reports 10 (2), 51-61, 2016 | 155 | 2016 |
| Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study GB Migliori, PM Thong, JW Alffenaar, J Denholm, M Tadolini, F Alyaquobi, ... European Respiratory Journal 58 (5), 2021 | 148 | 2021 |
| From therapeutic drug monitoring to model‐informed precision dosing for antibiotics SG Wicha, AG Märtson, EI Nielsen, BCP Koch, LE Friberg, JW Alffenaar, ... Clinical Pharmacology & Therapeutics 109 (4), 928-941, 2021 | 147 | 2021 |
| Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid … CWM Ong, GB Migliori, M Raviglione, G MacGregor-Skinner, G Sotgiu, ... European Respiratory Journal 56 (4), 2020 | 145 | 2020 |
| Voriconazole metabolism is influenced by severe inflammation: a prospective study A Veringa, M Ter Avest, LFR Span, ER van den Heuvel, DJ Touw, ... Journal of Antimicrobial Chemotherapy 72 (1), 261-267, 2016 | 135 | 2016 |
| Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on … RA Koster, JWC Alffenaar, B Greijdanus, DRA Uges Talanta 115, 47-54, 2013 | 135 | 2013 |
